Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's Gottlieb Applauds Drug Rebates At Point-Of-Sale

Mar 28 2018

• By Jessica Merrill

CNBC’s Meg Tirrell interviews Scott Gottlieb, M.D., Commissioner of Food and Drugs, U.S. FDA, at CNBC’s Healthy Returns conference March 28th in NYC ( — CNBC's Meg Tirrell interviews Scott Gottlieb at CNBC's Healthy Returns conference • Source: David Grogan/CNBC

Related Content

UnitedHealthcare Will Share The Savings: Point-Of-Sale Rebates Coming In 2019

Mar 07 2018

340B Hospitals May Be Losing Transparency Debate In Congress

Mar 16 2018

Drug Pricing Pundit Gottlieb Likely To Stay In His Lane At FDA

Apr 14 2017

EpiPen Price Story Highlights Growing Impact Of Drug Deductibles

Aug 30 2016

Just Do It: Lilly CEO Ricks On Rebates At The Pharmacy Counter

Jan 31 2018

FDA's Gottlieb: 'Pricing And Reimbursement Mischief' Holding Back Biosimilar Market

Mar 08 2018

Related Companies

Eli Lilly and Company

Additional Topics

United States Government Payers Pricing Strategies Market Access Policy Commercial Reimbursement Biosimilars BioPharmaceutical

More from Government Payers

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window